Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03144375 · ClinicalTrials.gov registry record · NA
QOL Outcomes in CRS With Polyps
A NA study, sponsored by University of Miami.
- Terminated
- Registry status
- NA
- Development phase
- 28
- Enrollment target
NCT03144375 is a NA study that was terminated before completion, run by University of Miami. The registered enrollment target is 28 participants.
The verdict
NCT03144375, a NA study, was terminated before completion, sponsored by University of Miami.
- TERMINATED
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
Study Summary
Chronic rhinosinusits (CRS) is common disease with reports of prevalence ranging from 4-16% in the western population. The main outcome measure for chronic disease treatment, such as CRS, is quality of life. Several large multi-institutional studies have shown that improvement in disease specific Quality of life was greater in patients who had surgery for their CRS with polyps. The timing of surgery in these patients has not been well studied but it is generally agreed upon that surgical candidates much had failed medical management. The definition of medical management varies greatly but usually includes some form of nasal or oral steroids and a prolonged ( \>10 days) course of antibiotics. Another known way to improve QOL is through education and individualized optimization. This has been utilized successfully in other fields with good success and improved QOL. Similar studies looking at combining non-surgical optimization and education have not been performed in CRS. This study aims to address this potential area for improvement in patient quality of life outcomes. Investigators plan to assess the potential role for pre-operative non-surgical medical and educational optimization in CRS standard of care treatment.
Interventions
- OTHER Medical optimization and education
- PROCEDURE Standard of Care sinus surgery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2015-12 |
| Est. Completion | 2016-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03144375
The ClinicalTrials.gov registry entry for NCT03144375 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Medical optimization and education is the first listed.
NCT03144375 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03144375 about?
NCT03144375 is a clinical study titled "QOL Outcomes in CRS With Polyps". Chronic rhinosinusits (CRS) is common disease with reports of prevalence ranging from 4-16% in the western population. The main outcome measure for chronic disease treatment, such as CRS, is quality of life. Several large multi-institutional studies have shown that improvement in disease specific Qu...
What is the current status of trial NCT03144375?
This trial is currently terminated. It is a NA study. The enrollment target is 28 participants. The study started on 2015-12. Estimated completion is 2016-10.
What interventions are being tested in trial NCT03144375?
The interventions under investigation include: Medical optimization and education (OTHER), Standard of Care sinus surgery (PROCEDURE).
Who is sponsoring clinical trial NCT03144375?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.